Inventor
PRAKASH THAZHA P
US89 patents
⚠️ This page may combine multiple inventors who share the name “PRAKASH THAZHA P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
20 patentsUS9181549B2Nov 10, 2015
Conjugated antisense compounds and their use
ISIS PHARMACEUTICALS INC69 citations99
US9127276B2Sep 8, 2015
Conjugated antisense compounds and their use
ISIS PHARMACEUTICALS INC136 citations99
US9005906B2Apr 14, 2015
Tetrahydropyran nucleic acid analogs
ISIS PHARMACEUTICALS INC163 citations99
US7696345B2Apr 13, 2010
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
ISIS PHARMACEUTICALS INC426 citations99
US7105499B2Sep 12, 2006
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
ISIS PHARMACEUTICALS INC233 citations99
US6639062B2Oct 28, 2003
Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom
ISIS PHARMACEUTICALS INC259 citations99
US6534639B1Mar 18, 2003
Guanidinium functionalized oligonucleotides and method/synthesis
ISIS PHARMACEUTICALS INC261 citations99
US6172209B1Jan 9, 2001
Aminooxy-modified oligonucleotides and methods for making same
ISIS PHARMACEUTICALS INC378 citations99
US8796437B2Aug 5, 2014
Tetrahydropyran nucleic acid analogs
ISIS PHARMACEUTICALS INC85 citations98
US7939677B2May 10, 2011
Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
ISIS PHARMACEUTICALS INC152 citations98
US7875733B2Jan 25, 2011
Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
ISIS PHARMACEUTICALS INC159 citations98
US7569686B1Aug 4, 2009
Compounds and methods for synthesis of bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC501 citations98
US6147200ANov 14, 2000
2'-O-acetamido modified monomers and oligomers
ISIS PHARMACEUTICALS INC466 citations98
US6403779B1Jun 11, 2002
Regioselective synthesis of 2′-O-modified nucleosides
ISIS PHARMACEUTICALS INC82 citations97
US9181550B2Nov 10, 2015
Compositions and methods for modulating apolipoprotein (a) expression
ISIS PHARMACEUTICALS INC16 citations96
US9163239B2Oct 20, 2015
Compositions and methods for modulating apolipoprotein C-III expression
ISIS PHARMACEUTICALS INC20 citations96
US9382540B2Jul 5, 2016
Compositions and methods for modulating angiopoietin-like 3 expression
ISIS PHARMACEUTICALS INC13 citations93
US9145558B2Sep 29, 2015
Compositions and methods for modulating HBV expression
ISIS PHARMACEUTICALS INC13 citations93
US7919612B2Apr 5, 2011
2′-substituted oligomeric compounds and compositions for use in gene modulations
ISIS PHARMACEUTICALS INC14 citations92
US6593466B1Jul 15, 2003
Guanidinium functionalized nucleotides and precursors thereof
ISIS PHARMACEUTICALS INC28 citations92
IONIS PHARMACEUTICALS INC
17 patentsUS10844379B2Nov 24, 2020
Conjugated antisense compounds and their use
IONIS PHARMACEUTICALS INC8 citations93
US9957504B2May 1, 2018
Compositions and methods for modulating apolipoprotein (a) expression
IONIS PHARMACEUTICALS INC8 citations93
US9932581B2Apr 3, 2018
Compositions and methods for modulating apolipoprotein C-III expression
IONIS PHARMACEUTICALS INC6 citations93
US9932580B2Apr 3, 2018
Compositions and methods for modulating HBV expression
IONIS PHARMACEUTICALS INC5 citations93
US9321799B2Apr 26, 2016
Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
IONIS PHARMACEUTICALS INC17 citations93
US10570169B2Feb 25, 2020
Conjugated antisense compounds and their use
IONIS PHARMACEUTICALS INC11 citations86
US11851655B2Dec 26, 2023
Compositions and methods for modulating apolipoprotein (a) expression
IONIS PHARMACEUTICALS INC3 citations84
US11299736B1Apr 12, 2022
Conjugated antisense compounds and their use
IONIS PHARMACEUTICALS INC3 citations84
US11084844B2Aug 10, 2021
Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
IONIS PHARMACEUTICALS INC8 citations84
US10927372B2Feb 23, 2021
Compositions and methods for modulating apolipoprotein C-III expression
IONIS PHARMACEUTICALS INC2 citations84
US10883104B2Jan 5, 2021
Compositions and methods for modulating apolipoprotein (a) expression
IONIS PHARMACEUTICALS INC5 citations84
US10683499B2Jun 16, 2020
Compositions and methods for modulating TTR expression
IONIS PHARMACEUTICALS INC5 citations84
US9994855B2Jun 12, 2018
Compositions and methods for modulating growth hormone receptor expression
IONIS PHARMACEUTICALS INC9 citations84
US9957292B2May 1, 2018
Compositions and methods for modulating angiopoietin-like 3 expression
IONIS PHARMACEUTICALS INC11 citations84
US9943604B2Apr 17, 2018
Targeted therapeutic nucleosides and their use
IONIS PHARMACEUTICALS INC9 citations84
US9738895B2Aug 22, 2017
Oligomeric compounds and methods
IONIS PHARMACEUTICALS INC10 citations84
US9714421B2Jul 25, 2017
Compositions and methods
IONIS PHARMACEUTICALS INC5 citations84
SWAYZE ERIC E
4 patentsUS8440803B2May 14, 2013
Tetrahydropyran nucleic acid analogs
SWAYZE ERIC E158 citations99
US8088904B2Jan 3, 2012
Tetrahydropyran nucleic acid analogs
SWAYZE ERIC E164 citations99
US8883752B2Nov 11, 2014
5′ and 2′ BIS-substituted nucleosides and oligomeric compounds prepared therefrom
SWAYZE ERIC E24 citations93
US8987435B2Mar 24, 2015
Oligomeric compounds and methods
SWAYZE ERIC E20 citations92
PRAKASH THAZHA P
3 patentsUS8993738B2Mar 31, 2015
Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
PRAKASH THAZHA P53 citations98
US8278425B2Oct 2, 2012
N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
PRAKASH THAZHA P333 citations96
US9127033B2Sep 8, 2015
5′ modified nucleosides and oligomeric compounds prepared therefrom
PRAKASH THAZHA P26 citations92
MERCK & CO INC
2 patentsALLERSON CHARLES
1 patentSETH PUNIT P
1 patentBHAT BALKRISHEN
1 patentMANOHARAN MUTHIAH
1 patentShowing the top 50 of 89 patents by PatentIndex Score.